Suminobu Ito

Early use of donepezil against psychosis and cognitive decline in Parkinson’s disease: a randomised controlled trial for 2 years

Hideyuki Sawada, Tomoko Oeda, Masayuki Kohsaka et al. · Journal of Neurology Neurosurgery & Psychiatry · 2018 · 47 citations · Full text

Medicine, Pharmacology, Psychiatry +17

Physiologically based pharmacokinetic modelling of the three‐step metabolism of pyrimidine using¹³C‐uracil as an<i>in vivo</i>probe

Suminobu Ito, Takeshi Kawamura, Makoto Inada et al. · British Journal of Clinical Pharmacology · 2005 · 27 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Reactogenicity and immunogenicity of BNT162b2 or mRNA-1273 COVID-19 booster vaccinations after two doses of BNT162b2 among healthcare workers in Japan: a prospective observational study

Toshio Naito, Nao Tsuchida, Susumu Kusunoki et al. · Expert Review of Vaccines · 2022 · 24 citations · Full text

Medicine, Immunology, Infectious Diseases +17

A randomized phase II study to assess the effect of adjuvant immunotherapy using α-GalCer-pulsed dendritic cells in the patients with completely resected stage II–IIIA non-small cell lung cancer: study protocol for a randomized controlled trial

Hideo Saka, Chiyoe Kitagawa, Yukito Ichinose et al. · Trials · 2017 · 18 citations · Full text

Medicine, Immunology, Oncology +17

A disease-specific iPS cell resource for studying rare and intractable diseases

Megumu K. Saito, Mitsujiro Osawa, Nao Tsuchida et al. · Inflammation and Regeneration · 2023 · 17 citations · Full text

Life Sciences, Cell Biology, Pathology +10